Unlock your genetic potential for better living
Uncover your unique advantage. Transform care, nurture customer loyalty, and stand out.
FlexHealth offers a new dimension to patient care. Harness genetic insights to personalize prescriptions, differentiate your services, and elevate your pharmacy in a competitive landscape.
How FlexHealth can benefit independent pharmacies?
✔ Position your pharmacy as a forward-thinking health partner by anticipating medication issues.
✔ Differentiate your pharmacy and boost revenue with industry leading PGx testing services.
✔ Deepen customer trust and loyalty by offering unmatched expertise in personalized medication.
✔ Elevate your pharmacy’s reputation through a dedication to cutting-edge personalized medicine.
Now is the best time to add PGx testing to your offering
99% of health care providers agree genetics affect medication efficacy.
76% of consumers on 3+ drugs are interested in PGx testing.
275,000 lives lost annually due to unoptimized medication.
Identify Safer Drug Options
Reduce Adverse Drug Events
Discover Personalized Medicine
FlexHealth empowers pharmacists to revolutionize patient care through PGx testing with personalized medicine and insights
Genetic variations mean two patients on the same drug and dose can have vastly different responses. What causes side effects in one might be benign for another. With PGx, empower your pharmacy to optimize medication strategies for every individual.
We tailor the sales process to fit your pharmacy's preferred approach, from on-the-spot testing to mail-out kits
How to Get Started
Learn more with a FREE 15-minute discovery call
Pharmacogenomics testing is the testing of certain genes to detect gene variants that determine how individuals may react to specific medications. With pharmacogenomics testing insight, healthcare providers may reduce the need for “trial-and-error” dosing and can substantially reduce the risk associated with Adverse Drug Events (ADEs).
Yearly there are 2.2 million serious adverse drug reactions, according to a report published by the Journal of the American Medical Association report. These ADEs lead to approximately 1.3 million emergency room (ER) visits per year, and $3.5 billion excess spend of medical costs.
FlexHealth currently offers pharmacogenomics (PGx) testing that identifies gene variants that influence drug metabolism and efficacy. The FDA has updated the label of more than 200 drugs to include pharmacogenomics information and the breadth of coverage continues to grow.
Examples of genes targeted by the FlexHealth pharmacogenomics (PG) Panel include:
• CYP2D6 is the best-studied drug-metabolizing enzyme and affects 25% of all prescription drugs
• CYP2C9 acts on 15% of drugs in clinical use
• CYP2C19 acts on 15% of drugs in clinical use
You and your healthcare provider will receive a comprehensive personalized genetic profile report that provides information on drug-drug and FDA approved drug-gene interactions.
Pharmaceutical companies routinely use pharmacogenomic (PGx) tests in clinical trials to identify and exclude people for whom the drug will be dangerous or ineffective or to better understand the efficacy of their clinical drug candidates. Medical centers around the world are using PGx tests on patients to avoid serious drug side effects, reduce trial-and-error, and achieve more efficacious prescribing. PGx testing is a crucial part of precision medicine, and with our patient/provider-friendly report, you can have a more informed discussion about your medication program.
Commercial insurance coverage is very limited but varies by plan and provider. They may cover PGx testing in some diagnostic situations including adverse drug reactions or lack of response to medication, pain management, cancer management, and management of many co-morbid conditions.
GINA is a U.S. federal law that protects against genetic discrimination in the workplace and through one’s health insurance. It also safeguards individual and family privacy of genetic information. With new advances in science, technology, and data management, GINA plays a vital role in establishing a baseline of protection for all Americans against discrimination. See links below for additional details.
Are you a health plan, provider, or health company?
FlexHealth is actively seeking collaboration with health plans, providers, and other health companies. Our core mission revolves around ensuring precision medicine becomes a standard of care for all patients. Through partnerships, we can help reduce healthcare costs, adverse drug reactions, and treatment failures, while optimizing patient outcomes.